1. Relationships between Type 1 interferon signatures and clinical features of the new-onset lupus patients in Japan.
- Author
-
Yuri Shirahama, Aki Hashimoto, Nobuyuki Ono, Yukiko Takeyama, Akihito Maruyama, Takuya Inoue, Yoshifumi Tada, and Hiroaki Niiro
- Subjects
- *
TYPE I interferons , *LEUCOCYTES , *SYSTEMIC lupus erythematosus , *HOSPITAL admission & discharge , *DNA antibodies - Abstract
Objectives: The objective of the study is to investigate the relationships between Type 1 interferon (T1-IFN) signatures and clinical characteristics of lupus patients. Methods: We examined 49 new-onset lupus patients who were diagnosed between 1999 and 2017. The patients treated with >10 mg of prednisolone or hydroxychloroquine were excluded from this study. Serum T1-IFN signatures were revealed by a functional reporter assay and standardized by recombinant IFN-α. Patient backgrounds, clinical findings, and treatments were retrospectively extracted from their electrical medical records. Clinical data were also available, including SLE Disease Activity Index of SLE patients on admission. Results: T1-IFN signatures of lupus patients closely correlated with lupus disease activities, such as SLE Disease Activity Index-2K, white blood cell, C3 levels, and the titre of double-strand DNA antibody. We found fever and acute lupus dermatitis closely associated with T1-IFN signature. Conclusions: In lupus patients, fever and acute lupus dermatitis are good indicators of a strong T1-IFN signature. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF